With A New CEO, Will AstraZeneca Change Its Approach In Emerging Markets?
This article was originally published in PharmAsia News
Executive Summary
Roche’s surging growth in China could hint at what’s coming to AstraZeneca in emerging markets as Pascal Soriot, Roche’s head of pharmaceuticals, takes over at AZ.